Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
MedTek eCoin
AddedMar 20, 2024
UpdatedJun 18, 2026
MedTek eCoin

MedTek eCoin

Seed

MedTek eCoin: Medical organization in Cedar Falls, Iowa. Founded in 2018 by Bilal Kaaki.

HQ
Cedar Falls, IA, US
Founded
2018
Overview
Compare
Fundraising
Employees

MedTek eCoin is a medical organization currently based in Cedar Falls, Iowa, United States.

It has been founded in 2018 by Bilal Kaaki.

MedTek eCoin - Similar Companies

Med-Tek logo

Med-Tek

med-tek.com

Medkord logo

Medkord

medkord.com

Turek Labs logo

Turek Labs

IR Medtek logo

IR Medtek

irmedtek.com

Mednet logo

Mednet

Sv-Medtech logo

Sv-Medtech

Meditech logo

Meditech

meditech.com

MedAux logo

MedAux

Medeo-health logo

Medeo-health

medeo-health.com

Medtel.com logo

Medtel.com

medtel.com

Medicreations logo

Medicreations

medicreations.com

MobileMedTek logo

MobileMedTek

Evon Medics logo

Evon Medics

Medcorder logo

Medcorder

medcorder.com

Medical Technology Enterprise Consortium logo

Medical Technology Enterprise Consortium

MedTek eCoin - Quick Facts

Who are MedTek eCoin's competitors?

Companies similar to MedTek eCoin include Med-Tek, Medkord, Turek Labs and IR Medtek.

When was MedTek eCoin founded?

MedTek eCoin was founded in 2018.

Where is MedTek eCoin's headquarters located?

MedTek eCoin's headquarters is located in Cedar Falls, IA, US.

When was MedTek eCoin's last funding round?

MedTek eCoin's most recent funding round was for $1.2M (USD) in August 2018.

How much has MedTek eCoin raised to-date?

As of Aug 20, 2018, MedTek eCoin has raised a total of $1.2M (USD).

How many employees does MedTek eCoin have?

MedTek eCoin has 5 employees as of Feb 5, 2024.

MedTek eCoin - Classification

Ownership
  • Private
Technology
  • HealthTech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
  • Small Business
Main Product
  • Medical
Tags
  • SaaS
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified